Development of new media formulations for cell culture operations based on regression models
The paper discusses modelling and optimization of multi-component cell culture medium. The specific productivity (Qp) was considered a function of the medium components and possible interactions described by linear factors, two-way interactions and squared terms that results in a high dimensional problem where the number of variables p (represented by the medium components and their interactions) is much larger than the number of observations n.
Principal Components Regression (PCR), Partial Least Squares (PLS), Lasso and Elastic Net regressions were compared as modelling tools to deal with a high dimensional [Formula: see text] problem. PCR and PLS regression models resulted in better prediction results and were used for robust optimization of the medium composition by a nonlinear optimization. The case studies show that it is possible to formulate new media that result in higher Qp than the ones provided by the initial media experiments available. Also, the multivariate statistical approach permitted us to select media that is most informative about the optimum thus permitting modelling and optimization with a reduced set of initial experiments.
Heat Stress Triggers Differential Protein Accumulation in the Extracellular Matrix of Sorghum Cell Suspension Cultures
Plants reprogram gene expression as an adaptive response to survive high temperatures. While the identity and functions of intracellular heat stress-responsive
proteins have been extensively studied, the heat response of proteins secreted to the extracellular matrix is unknown. Here, we used Sorghum bicolor, a species adapted for growth in hot climates, to investigate the extracellular heat-induced responses. When exposed to 40 C for 72 h, heat-sensitive Arabidopsis cell suspension cultures died, while ICSB338 sorghum cell cultures survived by activation of a transcriptional response characterized by the induction of
Gentaur.
Quantitative proteomic analysis of proteins recovered from cell culture medium revealed specific heat stress-induced protein accumulation within the sorghum secretome. Of the 265 secreted proteins identified, 31 responded to heat (2-fold change), with 84% possessing a predicted signal peptide for targeting to the classical secretory pathway. The differentially accumulated proteins have putative functions in metabolism, detoxification, and protein modifications. A germin (SORBI_3003G427700) was highly heat-inducible at both protein and gene level. Overall, our study reveals new insights into sorghum responses to heat and provides a useful resource of extracellular proteins that could serve as targets for developing thermotolerant crops. Data are available via ProteomeXchange with identifier PXD021536.
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
Sézary Syndrome (SS) is a rare aggressive epidermotropic cutaneous T-cell lymphoma (CTCL) defined by erythroderma, pruritis, and a circulating atypical CD4 + T-cell clonal population. The diversity of Sézary cell (SC) phenotype and genotype may reflect either plasticity or heterogeneity, which was difficult to evaluate dynamically until the achievement of long-term SC expansion. Therefore, we developed six defined culture conditions allowing for the expansion of SC defined by their phenotype and monoclonality in four of seven SS cases. Engraftment of SC through the intrafemoral route into immunodeficient NOD.Cg-Prkdc(scid)Il2rg(tm1Wjll)/SzJ (NSG) mice was achieved in 2 of 14 SS cases. Secondary xenograft by percutaneous injection mimicked most of the features of SS with dermal infiltration, epidermotropism, and blood spreading.
These models also allowed assessing the intra-individual heterogeneity of patient SC. Subclones sharing the same TCR gene rearrangement evolved independently according to culture conditions and/or after xenografting. This clonal selection was associated with some immunophenotypic plasticity and limited genomic evolution both in vitro and in vivo. The long-term amplification of SC allowed us to develop eight new SC lines derived from four different patients. These lines represent the cell of origin diversity of SC and provide new tools to evaluate their functional hallmarks and response to therapy.

eaaci2015
Horse Red Blood Cells |
88R-H002 |
Fitzgerald |
20 ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Horse Red Blood Cells |
Hamster Red Blood Cells |
88R-H003 |
Fitzgerald |
10 ml |
EUR 586.8 |
Description: Washed and freshly prepared 10% suspension of Hamster Red Blood Cells |
Mouse Red Blood Cells |
88R-M001 |
Fitzgerald |
10 ml |
EUR 354 |
Description: Washed and freshly prepared 10% suspension of Mouse Red Blood Cells |
Monkey Red Blood Cells |
88R-M003 |
Fitzgerald |
5 x 2 ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Monkey Red Blood Cells |
Mouse Red Blood Cells |
88R-M004 |
Fitzgerald |
5 x 2 ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Mouse Red Blood Cells |
Pig Red Blood Cells |
88R-P002 |
Fitzgerald |
20 ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Pig Red Blood Cells |
Rabbit Red Blood Cells |
88R-R001 |
Fitzgerald |
20 ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Rabbit Red Blood Cells |
Rat Red Blood Cells |
88R-R002 |
Fitzgerald |
5 x 2.0ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Rat Red Blood Cells |
Rat Red Blood Cells |
88R-R005 |
Fitzgerald |
25 ml |
EUR 392.4 |
Description: Washed and freshly prepared 10% suspension of Rat Red Blood Cells |
Sheep Red Blood Cells |
88R-S001 |
Fitzgerald |
100 ml |
EUR 614.4 |
Description: Washed and freshly prepared 10% suspension of Sheep Red Blood Cells |
Sheep Red Blood Cells |
88R-S003 |
Fitzgerald |
20 ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Sheep Red Blood Cells |
Sheep Red Blood Cells |
88R-S004 |
Fitzgerald |
10 ml |
EUR 625.2 |
Description: Glutaraldehyde-stabilized freshly prepared albumin sensitised Sheep Red Blood Cells |
Sheep Red Blood Cells |
88R-S005 |
Fitzgerald |
10 ml |
EUR 535.2 |
Description: Glutaraldehyde-stabilized freshly prepared tanned Sheep Red Blood Cells |
Turkey Red Blood Cells |
88R-T001 |
Fitzgerald |
20 ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Turkey Red Blood Cells |
Rabbit Red Blood Cells (100%) |
20-abx800015 |
Abbexa |
|
|
|
Sheep Red Blood Cells (100%) |
20-abx800032 |
Abbexa |
|
|
|
Goat Red Blood Cells (100%) |
20-abx800047 |
Abbexa |
|
|
|
Horse Red Blood Cells (100%) |
20-abx800062 |
Abbexa |
-
EUR 543.60
-
EUR 661.20
-
EUR 460.80
|
|
|
Horse Red Blood Cells (100%) |
abx800062-1L |
Abbexa |
1 L |
EUR 895.2 |
|
Donkey Red Blood Cells (100%) |
20-abx800077 |
Abbexa |
-
EUR 811.20
-
EUR 1011.60
-
EUR 577.20
|
|
|
Donkey Red Blood Cells (100%) |
abx800077-1L |
Abbexa |
1 L |
EUR 1429.2 |
|
Camel Red Blood Cells (100%) |
20-abx800092 |
Abbexa |
-
EUR 895.20
-
EUR 1963.20
-
EUR 693.60
|
|
|
Camel Red Blood Cells (100%) |
abx800092-1L |
Abbexa |
1 L |
EUR 3650.4 |
|
Dog Red Blood Cells (100%) |
20-abx800122 |
Abbexa |
|
|
|
Chicken Red Blood Cells (100%) |
20-abx800137 |
Abbexa |
|
|
|
Guinea Pig Red Blood Cells |
88R-1047 |
Fitzgerald |
15 ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Guinea Pig Red Blood Cells |
Guinea Pig Red Blood Cells |
88R-G002 |
Fitzgerald |
25 ml |
EUR 438 |
Description: Washed and freshly prepared 10% suspension of Guinea Pig Red Blood Cells |
Guinea Pig Red Blood Cells |
88R-P001 |
Fitzgerald |
15 ml |
EUR 327.6 |
Description: Glutaraldehyde-stabilized freshly prepared Guinea Pig Red Blood Cells |
Neural Stem Cells (iPSC from Blood Cells; Male) |
ASE-9234 |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 497.4 |
Description: 12 month |
Neural Stem Cells (iPSC from Blood Cells; Female) |
ASE-9234F |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 497.4 |
Description: 12 month |
Human Cord Blood CD34+ Cells Derived Endothelial Cells |
HEC23 |
Neuromics |
500,000+ Cells |
EUR 1296 |
Rabbit RED BLOOD CELLS HEPARIN 500mL* |
31159-5 |
Pel-Freez |
500mL |
EUR 986.28 |
Beagle dog Red Blood Cells (100%) |
20-abx800107 |
Abbexa |
|
|
|
Neurons (iPSC from Blood Cells; Male) |
ASE-9321 |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 375.9 |
Description: 12 month |
Neurons (iPSC from Blood Cells; Female) |
ASE-9321F |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 375.9 |
Description: 12 month |
Normal Human Peripheral Blood Mononuclear Cells, Frozen -100 million cells |
79059-2 |
BPS Bioscience |
100 million cells |
EUR 580 |
Description: Cryopreserved vial (30 x 10^6 cells) of freshly isolated primary human peripheral blood mononuclear cells (PBMCs) from a healthy donor, isolated from leukapheresis / apheresis samples using Ficoll gradient. After isolation, the PBMCs were stained to identify sub populations and evaluated for viability by flow cytometry. Cells were cryopreserved in serum-free Cryostor CS10 at a controlled rate. |
Astrocytes Mature (iPSC from Blood Cells; Male) |
ASE-9322M |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 546 |
Description: 12 month |
Astrocytes Mature (iPSC from Blood Cells; Female) |
ASE-9322MF |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 546 |
Description: 12 month |
Astrocytes Precursors (iPSC from Blood Cells; Male) |
ASE-9322P |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 448.8 |
Description: 12 month |
Astrocytes Precursors (iPSC from Blood Cells; Female) |
ASE-9322PF |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 448.8 |
Description: 12 month |
Dopaminergic Neurons (iPSC from Blood Cells; Male) |
ASE-9323 |
Applied StemCell |
1 vial |
EUR 448.8 |
Description: 12 month |
Dopaminergic Neurons (iPSC from Blood Cells; Female) |
ASE-9323F |
Applied StemCell |
1 vial |
EUR 448.8 |
Description: 12 month |
Normal Human Peripheral Blood Mononuclear Cells, Frozen |
79059-1 |
BPS Bioscience |
30 million cells |
EUR 220 |
Description: Cryopreserved vial (30 x 10^6 cells) of freshly isolated primary human peripheral blood mononuclear cells (PBMCs) from a healthy donor, isolated from leukapheresis / apheresis samples using Ficoll gradient. After isolation, the PBMCs were stained to identify sub populations and evaluated for viability by flow cytometry. Cells were cryopreserved in serum-free Cryostor CS10 at a controlled rate. |
Neurons Starter Kit (iPSC from Blood Cells; Male) |
ASE-9321K |
Applied StemCell |
1 Kit |
EUR 473.1 |
Description: 12 month |
Neurons Starter Kit (iPSC from Blood Cells; Female) |
ASE-9321KF |
Applied StemCell |
1 Kit |
EUR 473.1 |
Description: 12 month |
Mouse Lymph PrimaCell2: Normal Lymphatic Blood Vessel Endothelial Cells |
2-82072 |
CHI Scientific |
1 Kit |
Ask for price |
Rat Lymph PrimaCell2: Normal Lymphatic Blood Vessel Endothelial Cells |
2-82571 |
CHI Scientific |
1 Kit |
Ask for price |
Human Lymph PrimaCell2: Normal Lymphatic Blood Vessel Endothelial Cells |
2-96088 |
CHI Scientific |
1 Kit |
Ask for price |
Astrocytes Precursors Starter Kit (iPSC from Blood Cells; Male) |
ASE-9322PK |
Applied StemCell |
1 Kit |
EUR 497.4 |
Description: 12 month |
Astrocytes Precursors Starter Kit (iPSC from Blood Cells; Female) |
ASE-9322PKF |
Applied StemCell |
1 Kit |
EUR 497.4 |
Description: 12 month |
Dopaminergic Neurons Starter Kit (iPSC from Blood Cells; Male) |
ASE-9323K |
Applied StemCell |
1 vial |
EUR 546 |
Description: 12 month |
Dopaminergic Neurons Starter Kit (iPSC from Blood Cells; Female) |
ASE-9323KF |
Applied StemCell |
1 vial |
EUR 546 |
Description: 12 month |
Lysis-EZ L, White Blood Cell Lysis Buffer, 1X Strength Solution |
PL015 |
Bio Basic |
10mL |
EUR 70.44 |
|
Rat Lymph PrimaCell2: Normal Lymphatic Blood Vessel Endothelial Cells Growth Medium |
9-25071 |
CHI Scientific |
5 x 100 ml |
Ask for price |
Mouse Lymph PrimaCell2: Normal Lymphatic Blood Vessel Endothelial Cells Growth Medium |
9-32072 |
CHI Scientific |
5 x 100 ml |
Ask for price |
Human Lymph PrimaCell2: Normal Lymphatic Blood Vessel Endothelial Cells Growth Medium |
9-46088 |
CHI Scientific |
5 x 100 ml |
Ask for price |
white plates |
1270-20 |
Biovision |
each |
EUR 117.6 |
Human Lymph Tissue Preparation Buffer 2: Normal Lymphatic Blood Vessel Endothelial Cells |
9-80088 |
CHI Scientific |
1 x 100 ml |
Ask for price |
Mouse Lymph Tissue Preparation Buffer 2: Normal Lymphatic Blood Vessel Endothelial Cells |
9-80186 |
CHI Scientific |
1 x 100 ml |
Ask for price |
Rat Lymph Tissue Preparation Buffer 2: Normal Lymphatic Blood Vessel Endothelial Cells |
9-80278 |
CHI Scientific |
1 x 100 ml |
Ask for price |
iPSC (iPSC from Blood Cells; Male, Master Lines for Neural Differentiation) *Academic Price |
ASE-9109 |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 1882.5 |
Description: 12 month |
iPSC (iPSC from Blood Cells; Feale, Master Lines for Neural Differentiation) *Academic Price |
ASE-9110 |
Applied StemCell |
1 vial (1 x 10^6) |
EUR 1882.5 |
Description: 12 month |
Lysozyme (Egg White) |
abx082183-5g |
Abbexa |
5 g |
EUR 226.8 |
|
Lysozyme (Egg White) |
abx082564-5g |
Abbexa |
5 g |
EUR 243.6 |
|
Lysozyme, Egg White |
L2100-005 |
GenDepot |
5g |
EUR 208.8 |
Lysozyme, Egg White |
L2100-010 |
GenDepot |
10g |
EUR 262.8 |
Lysozyme, Egg White |
L2100-100 |
GenDepot |
100g |
EUR 699.6 |
Safe-White™ |
G108-W |
ABM |
1.0 ml |
EUR 85.2 |
Labeling Tape, White |
TP003W |
Bio Basic |
1ROLLS, 1 UNIT |
EUR 64.42 |
|
Paraffin Wax Dispenser |
Paraffin wax, granular (56 - 60) |
Paraffin wax, granular (56 - 60) |
MagSi-WAX |
MagSi-WAX |
MagSi-WAX |
Wax Paper For Se235 Pkg100 |
neo WAX 30mg Plate SPE Columns |
neo WAX 100mg/3mL SPE Columns |
neo WAX 200mg/6mL SPE Columns |
Optimization of Viable Glioblastoma Cryopreservation for Establishment of Primary Tumor Cell Cultures
Background: Technologies related to the establishment of primary tumor cell cultures from solid tumors, including glioblastoma, are increasingly important to oncology research and practice. However, processing of fresh tumor specimens for establishment of primary cultures on the day of surgical collection is logistically difficult. The feasibility of viable cryopreservation of glioblastoma specimens, allowing for primary culture establishment weeks to months after surgical tumor collection and freezing, was demonstrated by Mullins et al. in 2013, with a success rate of 59% that was not significantly lower than that achieved with fresh tumor tissue. However, research targeting optimization of viable glioblastoma cryopreservation protocols for establishment of primary tumor cultures has been limited.
Objectives: The objective of this study was to optimize glioblastoma cryopreservation methods for viable cryobanking and to determine if two-dimensional (2D) or three-dimensional (3D) culture conditions were more supportive of glioblastoma growth after thawing of frozen tumor specimens.
Methods: Portions of eight human glioblastoma specimens were cryopreserved by four different protocols differing in the time of enzymatic digestion (before or after cryopreservation), and in the type of cryopreservation media (CryoStor CS10 or 10% dimethyl sulfoxide and 90% fetal calf serum). After 1 month, frozen tissues were thawed, enzymatically digested, if not digested before, and used for initiation of 2D or 3D primary tumor cultures to determine viability.
Results: Among the tested cryopreservation and culturing protocols, the most efficient combinations of cryopreservation and culture were those associated with the use of CryoStor CS10 cryopreservation medium, enzymatic digestion before freezing, and 2D culturing after thawing with a successful culture rate of 8 out of 8 cases (100%). Two-dimensional cultures were in general more efficient for the support of tumor cell growth after thawing than 3D cultures.
Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2+ breast cancer cells on biomarkers of monocyte antitumor activity
Background: Immune activities of monocytes (MOs) can be altered within the microenvironment of solid malignancies, including breast cancer. Metformin (1,1-dimethylbiguanide hydrochloride, MET), has been shown to decrease tumor cell proliferation, but its effects have yet to be explored with respect to MOs (monocytes) activity during their crosstalk with breast cancer cells. Here, we investigated the effects of MET on overall phenotypic functional activities, including cellular immunometabolism and protective redox signaling based-biomarkers, intracellular free calcium ions (ifCa2+), phagocytosis and co-operative cytokines (IFN-γ and IL-10) of autologous MOs before and during their interplay with primary ER-/PR-/HER2+ breast cancer cells.
Methods: Human primary breast cancer cells were either cultured alone or co-cultured with autologous MOs before treatment with MET.
Results: MET downregulated breast cancer cell proliferation and phagocytosis, while having no significant effect on the ratio of phosphorylated Akt (p-Akt) to total Akt. Additionally, we observed that, in the absence of MET treatment, the levels of lactate dehydrogenase (LDH)-based cytotoxicity, catalase, ifCa2+, IL-10 and arginase activity were significantly reduced in co-cultures compared to levels in MOs cultured alone whereas levels of inducible nitric oxide synthase (iNOS) activity were significantly increased. In contrast, MET treatment reduced the effects measured in co-culture on the levels of LDH-based cytotoxicity, arginase activity, catalase, ifCa2+, and IFN-γ. MET also induced upregulation of both iNOS and arginase in MO cells, although the increase did not reach significant difference for iNOS activity.
Moreover, MET induced a robust increase of superoxide dismutase (SOD) activity in MOs, but not in MOs co-cultured with breast cancer cells. Furthermore, MET markedly upregulated the levels of IFN-γ production and downregulated those of IL-10 in isolated MOs, while inducing a slight opposing up-regulation of IL-10 production in co-cultures.
MagIso CD8 Memory T Cell Isolation Kit, Human |
WHK-B026 |
Creative Diagnostics |
20 tests, 200 tests |
Ask for price |
CD45RO Antibody (T-cell marker) |
V2419IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2419SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2420-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2420-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2420IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2420SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V7044-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD45RO is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. CD45RO contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus is classified as a receptor type PTP. It has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. It also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. [RefSeq] |
CD45RO Antibody (T-cell marker) |
V7044-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: CD45RO is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. CD45RO contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus is classified as a receptor type PTP. It has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. It also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. [RefSeq] |
CD45RO Antibody (T-cell marker) |
V7044IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: CD45RO is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. CD45RO contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus is classified as a receptor type PTP. It has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. It also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. [RefSeq] |
CD45RO Antibody (T-cell marker) |
V7044SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD45RO is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. CD45RO contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus is classified as a receptor type PTP. It has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. It also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. [RefSeq] |
CD45RO Antibody (T-cell marker) |
V2237-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45) called CD45RO (4th Leucocyte Typing Workshop: Code No. N31). The epitope recognized by this antibody is sensitive to neuraminidase digestion. CD45RO is found on mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. The CD45RO antibody shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, antibody to CD45RO is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2237-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45) called CD45RO (4th Leucocyte Typing Workshop: Code No. N31). The epitope recognized by this antibody is sensitive to neuraminidase digestion. CD45RO is found on mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. The CD45RO antibody shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, antibody to CD45RO is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2237IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45) called CD45RO (4th Leucocyte Typing Workshop: Code No. N31). The epitope recognized by this antibody is sensitive to neuraminidase digestion. CD45RO is found on mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. The CD45RO antibody shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, antibody to CD45RO is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2237SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45) called CD45RO (4th Leucocyte Typing Workshop: Code No. N31). The epitope recognized by this antibody is sensitive to neuraminidase digestion. CD45RO is found on mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. The CD45RO antibody shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, antibody to CD45RO is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2416-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2416-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2416SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2419-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody (T-cell marker) |
V2419-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
M1299-10 |
Biovision |
each |
Ask for price |
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
M1299-20 |
Biovision |
each |
Ask for price |
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
M1299-30 |
Biovision |
each |
Ask for price |
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
M1299-40 |
Biovision |
each |
Ask for price |
Untransduced T Cells |
78170-1 |
BPS Bioscience |
1 vial |
EUR 1250 |
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells. |
Untransduced T Cells |
78170-2 |
BPS Bioscience |
5 vials |
EUR 3325 |
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells. |
CD45RO Antibody Cocktail (T-cell marker) |
V2421-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody cocktail reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody Cocktail (T-cell marker) |
V2421-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody cocktail reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody Cocktail (T-cell marker) |
V2421IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody cocktail reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
CD45RO Antibody Cocktail (T-cell marker) |
V2421SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody cocktail reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. |
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx159398 |
Abbexa |
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx159399-100ul |
Abbexa |
100 ul |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx159400-100ul |
Abbexa |
100 ul |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx159401-100ul |
Abbexa |
100 ul |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx159402-100ul |
Abbexa |
100 ul |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx159403-100ul |
Abbexa |
100 ul |
EUR 526.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx159404-100ul |
Abbexa |
100 ul |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx159405-100ul |
Abbexa |
100 ul |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx159406-100ul |
Abbexa |
100 ul |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx137099 |
Abbexa |
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx139124-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx139125-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx139126-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx139127-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx140007-01mg |
Abbexa |
0.1 mg |
EUR 343.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx140008-01mg |
Abbexa |
0.1 mg |
EUR 343.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx140009-01mg |
Abbexa |
0.1 mg |
EUR 343.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx140102-01mg |
Abbexa |
0.1 mg |
EUR 376.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx140341-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx140432-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx134635 |
Abbexa |
-
EUR 427.20
-
EUR 678.00
-
EUR 360.00
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx134645 |
Abbexa |
-
EUR 427.20
-
EUR 678.00
-
EUR 360.00
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx134646 |
Abbexa |
-
EUR 427.20
-
EUR 678.00
-
EUR 360.00
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx146722-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx146728-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx000694 |
Abbexa |
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx001304 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx009476 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx125313 |
Abbexa |
-
EUR 594.00
-
EUR 844.80
-
EUR 427.20
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx111482 |
Abbexa |
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx012383-100ul |
Abbexa |
100 ul |
EUR 493.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx015800-100ul |
Abbexa |
100 ul |
EUR 493.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx019049-100ug |
Abbexa |
100 ug |
EUR 410.4 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx021410-02mg |
Abbexa |
0.2 mg |
EUR 886.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx028455-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx028455-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx028456-400ul |
Abbexa |
400 ul |
EUR 661.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx028456-80l |
Abbexa |
80 µl |
EUR 385.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx200030-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx200854 |
Abbexa |
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx320336 |
Abbexa |
|
|
|
T-Cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx242941 |
Abbexa |
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
20-abx326208 |
Abbexa |
|
|
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413138-01mg |
Abbexa |
0.1 mg |
EUR 526.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413139-025mg |
Abbexa |
0.25 mg |
EUR 678 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413254-01mg |
Abbexa |
0.1 mg |
EUR 543.6 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413340-025mg |
Abbexa |
0.25 mg |
EUR 678 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413341-05mg |
Abbexa |
0.5 mg |
EUR 994.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413342-01mg |
Abbexa |
0.1 mg |
EUR 526.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413343-25ug |
Abbexa |
25 ug |
EUR 326.4 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413612-2ml |
Abbexa |
2 ml |
EUR 727.2 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413766-01mg |
Abbexa |
0.1 mg |
EUR 610.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx413842-01mg |
Abbexa |
0.1 mg |
EUR 543.6 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx414255-025mg |
Abbexa |
0.25 mg |
EUR 710.4 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx414488-025mg |
Abbexa |
0.25 mg |
EUR 678 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx414492-25ug |
Abbexa |
25 ug |
EUR 326.4 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx414713-025mg |
Abbexa |
0.25 mg |
EUR 678 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx414714-1mg |
Abbexa |
1 mg |
EUR 994.8 |
|
T-cell Surface Glycoprotein CD4 (CD4) Antibody |
abx414765-025mg |
Abbexa |
0.25 mg |
EUR 678 |
|
Tags:
cdna amd,
cdna application,
cdna avm,
cdna for qpcr,
cdna library,
cdna sbs,
cdna sequence,
cdna sequencing,
cdna stock,
cdna stock price,
cdna synthesis,
cdna synthesis pcr,
cdna synthesis protocol,
cdna vs genomic,
cdna vs genomic dna,
cdna.tv,
cdna2,
cdnacp,
cdnaf,
cdname,
cdnap,
cdnaturally,
pcr 730 perryville mo,
pcr covid,
pcr covid 19 test,
pcr cycle,
pcr definition,
pcr inc,
pcr inhibitor,
pcr kits price,
pcr kits/reagents,
pcr lab test,
pcr machine,
pcr meaning,
pcr primers,
pcr procedure pdf,
pcr process,
pcr rapid test,
pcr steps,
pcr test accuracy,
pcr test cost,
pcr test near me,
pcr test result time,
pcr testing accuracy,
pcr tests,
pcr vs antigen testing